Surgical gloves vs examination gloves: standards, sterility and buyer evidence

Start with the manufacturer’s stated intended purpose, not the glove material, colour or box design. Then build the evidence file that belongs to that purpose and destination market.

• Examination glove: intended for medical examinations or diagnostic and therapeutic procedures, with the exact classification and evidence confirmed for the market.
• Surgical glove: intended for surgical procedures, with product, conformity and sterile evidence that supports that use.
• Sterile examination glove: still an examination glove, but the sterility aspects add their own conformity and validation requirements.
• Dual-use glove: may also make a wearer-protection claim under PPE rules, which requires a separate evidence path.
• Approval rule: a familiar shape, material or standard number never substitutes for the exact intended purpose and current documents.

MHRA guidance says gloves intended to protect a patient during a medical examination or surgical procedure are medical devices. It describes examination gloves as usually Class I and surgical gloves as usually Class IIa. Surgical gloves therefore need the applicable certificate from a UK Approved Body or EU Notified Body for the route being used.

The word usually matters. Classification is a legal decision for the exact device, based on its intended purpose and the current rules. A buyer should not copy a classification from a competitor product or infer it from the product name. For Great Britain, also confirm MHRA registration, the legal manufacturer and the UK Responsible Person where the manufacturer is outside the UK.

• Match the intended-purpose statement across the declaration, label, instructions and sales material.
• Confirm the exact product reference, size and formulation scope on every certificate and report.
• Check the conformity marking and the current route for Great Britain, Northern Ireland, the EU or another destination.
• Record NewGlove’s economic-operator role separately from the legal manufacturer and production facility.

A sterile claim is not proven by sealed packaging or a surgical description. It needs a defined sterilisation method, validated process, routine release controls and packaging evidence that maintains the sterile barrier for the labelled shelf life. The current Great Britain designated-standards notice lists EN 556-1:2024 and EN 556-2:2024 for devices designated sterile, alongside standards covering sterile-barrier systems and sterilisation methods.

Ask whether sterilisation is performed by the manufacturer or a subcontractor, and confirm that the current certificate and validation scope cover the actual site, product, packaging configuration and process. Review transport and ageing evidence as well as seal integrity. A sterilised glove that has damaged packaging or has passed its expiry date should not be treated as sterile.

• Sterilisation method and validated cycle for the exact product and pack.
• Routine release criteria, lot traceability and records for the supplied lot.
• Sterile-barrier design, sealing validation and packaging integrity evidence.
• Shelf-life, ageing, transport and storage evidence connected to the final pack.
• Current subcontractor and conformity scope where any critical stage is outsourced.

EN 455 is the European series for single-use medical gloves. The current Great Britain designated list includes EN 455-1:2020+A2:2024 for freedom from holes, EN 455-2:2024 for physical properties, EN 455-3:2023 for biological evaluation and EN 455-4:2009 for shelf-life determination.

EN 455 is relevant to medical gloves, but a data sheet that says only EN 455 is not a complete approval file. Buyers should see which parts and editions were assessed, which product references and sizes the evidence covers, and how the reports connect to the declaration, label, sterile status and intended use. Do not assume that examination-glove EN 455 evidence proves surgical qualification.

ISO 10282:2023 specifies requirements for packaged sterile rubber gloves intended for surgical procedures. ISO states explicitly that it does not apply to examination or procedure gloves. ASTM D3577-19(2023) similarly covers packaged sterile rubber surgical gloves and includes natural-rubber and synthetic-rubber types.

A standard reference should be tied to an exact report or certificate, not copied from a catalogue. Check the edition, product material, sizes, test laboratory, report date and acceptance results. The standards do not replace regulatory classification, conformity assessment, sterilisation validation or workplace and clinical selection.

ASTM D6319-19(2023) covers nitrile examination gloves used in medical examinations and diagnostic and therapeutic procedures. Its scope includes ambidextrous or paired examination gloves and sterile, non-sterile or bulk non-sterile configurations. That does not turn a D6319 examination glove into a surgical glove.

For a US surgical-glove programme, buyers should look at the surgeon’s-glove regulatory route and relevant surgical evidence, including ASTM D3577 where applicable. For a nitrile examination glove, ASTM D6319 may be relevant. In either case, FDA, GB or EU status must be confirmed independently for the destination market.

Before describing a product as surgical or sterile, assemble one controlled file that connects the product, legal roles, test evidence and delivered stock.

• Final label, instructions, intended purpose, product reference, material, powder status, sizes and sterile status.
• Legal manufacturer, NewGlove’s role, responsible person or representative, importer and distributor details as applicable.
• Declaration of conformity, classification rationale, registration and current Approved Body or Notified Body certificate for the exact scope.
• EN 455 Parts 1 to 4 evidence for the exact product, formulations and sizes where claimed.
• ISO 10282:2023 or ASTM D3577-19(2023) evidence only where the exact product and destination claim require it.
• Sterilisation validation, routine release, sterile-barrier packaging, ageing, transport, storage and shelf-life evidence.
• Biological evaluation, latex-protein and powder-residue evidence where relevant.
• Lot traceability, complaint, vigilance, change-control and post-market responsibilities.

NewGlove can discuss sourcing programmes through its contract manufacturing relationship in Malaysia. That statement does not confirm that a surgical or sterile product is available, approved or supported. Any programme must remain blocked until the exact product, facility, legal roles and destination-market evidence pass review.

A useful opening brief states the intended procedure, material preference, sterile status, size range, destination, estimated volume and documents already available. It should also identify special claims such as latex-free, accelerator-free, chemotherapy-drug resistance or double gloving, because each needs separate exact-product evidence.